Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rémi Brouard"'
Autor:
Mats Åkerlund, Kerstin Wolff, Tadeusz Laudański, Thomas Bossmar, Per Olofsson, Margareta Steinwall, Gérard Le-Fur, Rémi Brouard, Remigiusz Urban
Publikováno v:
Gynecological Endocrinology. 20:104-109
Relcovaptan (SR 49059) is a non-peptide, orally active vasopressin V1a receptor inhibitor. The effect on uterine contractions in 18 women with preterm labor in pregnancy weeks 32-36 was assessed in a double-blind investigation. The inclusion criterio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62f1a7f646b6e2f4f5570a935df37252
https://doi.org/10.1080/09513590400021144
https://doi.org/10.1080/09513590400021144
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 107:614-619
Objective To investigate the clinical effect of SR49059 when given shortly before the onset of menstruation as a preventative treatment of dysmenorrhoea. Design A double-blind, randomised, placebo-controlled, cross-over trial in complete block design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04be84e109a9dd2e3b449098c62a5ab0
https://doi.org/10.1111/j.1471-0528.2000.tb13302.x
https://doi.org/10.1111/j.1471-0528.2000.tb13302.x
Autor:
Anna Kostrzewska, Thomas Bossmar, Claudine Secradeil‐Le Gal, Tadeusz Laudański, Adam Lemancewicz, Rémi Brouard, Margareta Steinwall, Mats Åkerlund
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 106:1047-1053
Objective To test binding affinities for, and inhibitory effects on, myometrium of some oxytocin and vasopressin antagonists with respect to their therapeutic potential. Design Receptor binding studies on transfected cell lines. In vitro contractilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b97061644269c4f432bbdb121ca048
https://doi.org/10.1111/j.1471-0528.1999.tb08112.x
https://doi.org/10.1111/j.1471-0528.1999.tb08112.x
Autor:
Gilbert Deray, Corinne Isnard Bagnis, Anne Françoise Leenhardt, Rémi Brouard, Alain Baumelou, Françoise Raymond, José Necciari
Publikováno v:
Clinical Drug Investigation. 16:319-328
Objectives: To assess the tolerability, pharmacodynamic effects and pharmacokinetic parameters after repeated doses of clopidogrel (Plavix®) in patients with moderate or severe renal failure. Patients: Eight patients with severe renal failure (endog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9f6ec41c1af535e7f600770f98f5ec
https://doi.org/10.2165/00044011-199816040-00006
https://doi.org/10.2165/00044011-199816040-00006
Autor:
Daniel Hayoz, Hans R. Brunner, Roger Weber, Jean-Paul Lahmy, Antoinette Pechère-Bertschi, Rémi Brouard, Vjekoslav Gerc, Michel Burnier
Publikováno v:
Hypertension. 30:1121-1127
Abstract We have evaluated the efficacy of SR 49059, a new orally active and specific vasopressin V 1 receptor antagonist (arginine-vasopressin [AVP]), in the blockade of the vascular effects of exogenous AVP in healthy subjects. In preliminary exper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feebfaa162fbf8e8a2b3b8a2b2deb1f2
https://doi.org/10.1161/01.hyp.30.5.1121
https://doi.org/10.1161/01.hyp.30.5.1121
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 104:471-477
Objective To test the effect of SR 49059, an orally active, nonpeptide, selective and specific antagonist of the vasopressin V1a receptors in humans. Design A placebo-controlled, double-blind, cross-over trial. Setting The Department of Obstetrics an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b30d4415135cedc6b9fcca396181e14
https://doi.org/10.1111/j.1471-0528.1997.tb11500.x
https://doi.org/10.1111/j.1471-0528.1997.tb11500.x
Autor:
Jürg Nussberger, Hans R. Brunner, Michel Burnier, Catherine Armagnac, Bernard Waeber, Jérôme Biollaz, Rémi Brouard, Michael Hagman
Publikováno v:
Hypertension. 25:602-609
Abstract We investigated the short-term and sustained hormonal and renal effects of angiotensin II (Ang II) receptor blockade in normotensive healthy volunteers. Twenty-four subjects maintained on a fixed sodium diet were randomized to receive for 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9e5d2c9ece80823e83d2cb5818dce7
https://doi.org/10.1161/01.hyp.25.4.602
https://doi.org/10.1161/01.hyp.25.4.602
Autor:
M. Abitbol, Roland Rymer, Rémi Brouard, Carine Terem, Guillaume Ravard, Lounis Hamzi, Mourad Boudiaf, Jian Fang Yeh, Philippe Soyer
Publikováno v:
Journal of computer assisted tomography. 28(4)
Objective: Among the various organs that may be affected by hereditary hemorrhagic telangiectasia (HHT), the liver can show various degrees of vascular and parenchymal involvement. The purpose of this prospective study comprising a large series of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af10f627ba7d1ccdd2f67d7cccf5cecc
https://pubmed.ncbi.nlm.nih.gov/15232380
https://pubmed.ncbi.nlm.nih.gov/15232380
Publikováno v:
Revue de Chirurgie Orthopédique et Traumatologique. 98:S280-S281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b83180c673505cf5cddd23d4e0adf11d
https://doi.org/10.1016/j.rcot.2012.08.017
https://doi.org/10.1016/j.rcot.2012.08.017
Autor:
M. Depairon, G. Bizzini, Daniel Hayoz, Bernard Noël, Rémi Brouard, M. Burnier, C. Fauveau, A. Rouillon, Hans R. Brunner
Publikováno v:
Rheumatology (Oxford, England). 39(10)
Objective. To assess whether vasopressin V1a receptor blockade reduces the abnormal vasoactive response to cold in patients suffering from Raynaud’s phenomenon (RP). Methods. SR 49059, an orally active, non-peptidic vasopressin V1a receptor antagon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bd3ab48122239035878ada44635daf
https://pubmed.ncbi.nlm.nih.gov/11035135
https://pubmed.ncbi.nlm.nih.gov/11035135